Allopurinol, a classic xanthine oxidase inhibitor, has been also shown to suppress atrial fibrillation promotion by preventing both electrical and structural remodeling in a canine model of atrial pacing-induced LV dysfunction [275], and its use for >6 months was associated with a reduced risk of incident AF in the elderly [276]. This evidence concerns the gene XDH and atrial fibrillation.